ARTICLE | Company News
Spring Bank, Arbutus deal
December 30, 2016 1:41 AM UTC
The companies partnered to conduct preclinical studies combining Spring Bank's SB 9200 and Arbutus' AB-423 to treat HBV infection. SB 9200, a small molecule targeting DEAD box polypeptide 58 (DDX58; R...